32 related articles for article (PubMed ID: 26174002)
1. Factors related to inter-observer reproducibility of conventional Pap smear cytology: a multilevel analysis of smear and laboratory characteristics.
Baena A; Guevara E; Almonte M; Arias-Stella J; Sasieni P; Sanchez GI
Cytopathology; 2017 Jun; 28(3):192-202. PubMed ID: 28029192
[TBL] [Abstract][Full Text] [Related]
2. Nationwide Rereview of Normal Cervical Cytologies before High-Grade Cervical Lesions or before Invasive Cervical Cancer.
Edvardsson H; Wang J; Andrae B; Sparén P; Strander B; Dillner J
Acta Cytol; 2021; 65(5):377-384. PubMed ID: 34077926
[TBL] [Abstract][Full Text] [Related]
3. A Fuzzy-C-Means-Clustering Approach: Quantifying Chromatin Pattern of Non-Neoplastic Cervical Squamous Cells.
Tang JR; Mat Isa NA; Ch'ng ES
PLoS One; 2015; 10(11):e0142830. PubMed ID: 26560331
[TBL] [Abstract][Full Text] [Related]
4. Results of an Australian trial using SurePath liquid-based cervical cytology with FocalPoint computer-assisted screening technology.
Bowditch RC; Clarke JM; Baird PJ; Greenberg ML
Diagn Cytopathol; 2012 Dec; 40(12):1093-9. PubMed ID: 22045553
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
[TBL] [Abstract][Full Text] [Related]
6. A retrospective validation of the FocalPoint GS slide profiler NFR technology by analysis of interval disease outcomes compared with manual cytology.
Nuttall DS; Hillier S; Clayton HR; Savage AJ; Martin CM; O'Leary JJ
Cancer Cytopathol; 2019 Apr; 127(4):240-246. PubMed ID: 30825407
[TBL] [Abstract][Full Text] [Related]
7. Split-sample analysis of discarded cells from liquid-based Pap smear sampling devices.
Rinas AC; Mittman BW; Le LV; Hartmann K; Cayless J; Singh HK
Acta Cytol; 2006; 50(1):55-62. PubMed ID: 16514841
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
[TBL] [Abstract][Full Text] [Related]
9. Morphologic analysis of false negative SurePath® slides using Focalpoint™ GS computer-assisted cervical screening technology: An Australian experience.
Bowditch RC; Clarke JM; Baird PJ; Greenberg ML
Diagn Cytopathol; 2015 Nov; 43(11):870-8. PubMed ID: 26174002
[TBL] [Abstract][Full Text] [Related]
10. [Computer-assisted diagnostics in cervical cytology].
Ikenberg H
Pathologe; 2011 Nov; 32(6):476-83. PubMed ID: 22038134
[TBL] [Abstract][Full Text] [Related]
11. Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practice.
Cox JT
J Natl Compr Canc Netw; 2004 Nov; 2(6):597-611. PubMed ID: 19780303
[TBL] [Abstract][Full Text] [Related]
12. Challenging lesions in cervical cytology: The elusive HSIL.
Torous VF
Cytopathology; 2024 Jan; 35(1):48-59. PubMed ID: 37706620
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
